About: Chelation therapy   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

When the functioning of metallothionein (MT) proteins is defective, it can result in impaired brain development and extreme sensitivity to environmental substances. The expected consequences of defective MT proteins (and subsequent buildup of toxic metals and minerals in the blood and nervous system) during gestation or early infancy are consistent with several classic symptoms of autism.

AttributesValues
rdfs:label
  • Chelation therapy
rdfs:comment
  • When the functioning of metallothionein (MT) proteins is defective, it can result in impaired brain development and extreme sensitivity to environmental substances. The expected consequences of defective MT proteins (and subsequent buildup of toxic metals and minerals in the blood and nervous system) during gestation or early infancy are consistent with several classic symptoms of autism.
  • Chelation therapy is the standard treatment for any type of heavy metal poisoning and radiation sickness where it is suspected the radioactive material is still in the body. It uses chemicals that bind to metal ions in order to turn them into inert compounds that can be disposed of in the urine and feces. Chelation therapy is usually very safe. The chelation agents themselves will not interact with human tissues. Depending on the location of the heavy metal, they can be given intravenously, with an intramuscular injection, or orally.
sameAs
dcterms:subject
dbkwik:autism/prop...iPageUsesTemplate
abstract
  • When the functioning of metallothionein (MT) proteins is defective, it can result in impaired brain development and extreme sensitivity to environmental substances. The expected consequences of defective MT proteins (and subsequent buildup of toxic metals and minerals in the blood and nervous system) during gestation or early infancy are consistent with several classic symptoms of autism. Studies of autistic patients by Dr. William Walsh and Dr. Anjum Usman found that many had abnormal levels of copper and zinc in the blood, in concentrations which provided a reliable indication of the degree of MT function.
  • Chelation therapy is the standard treatment for any type of heavy metal poisoning and radiation sickness where it is suspected the radioactive material is still in the body. It uses chemicals that bind to metal ions in order to turn them into inert compounds that can be disposed of in the urine and feces. Heavy metals poison the body by interfering with regular bodily functions through a chemical process. Passing the metal ions through the liver and kidneys, which usually process waste, merely results in the destruction of those tissues as well, resulting in the metal ions actually being concentrated in those areas. Chelation uses chemicals which chemically combine with metals, creating inert compounds that will not interact with living tissue (much in the same way as the dangerous metal sodium combines with the dangerous gas chlorine to form salt, only the compounds are much more complicated in this case). These chemicals are also used in industrial processes for the same purpose, often to separate precious metals. DMSA is the most common chelating agent, and each chelating agent has a different chemical affinity for different heavy metals. Chelation therapy is usually very safe. The chelation agents themselves will not interact with human tissues. Depending on the location of the heavy metal, they can be given intravenously, with an intramuscular injection, or orally.
is treatment of
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software